ATOVAQUONE
NDC 50268-119, ATOVAQUONE, suspension, from AvPAK.
- Product NDC
- 50268-119
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202960
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-119 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE750 mg/5mL
Pharmacologic classes
Antimalarial [EPC]; Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-119-12 | 50268011912 | 20 CUP in 1 BOX (50268-119-12) / 5 mL in 1 CUP (50268-119-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4124ad97-f6b9-8afb-e063-6294a90ab970
Use it
Look up 50268-119 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-119 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-119. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.